One-year follow-up of the immune profile in serum and selected sites of generalized and localized aggressive periodontitis.

BACKGROUND: The local and systemic immunological profiles of important inflammatory mediators in the localized (LAgP) and generalized (GAgP) forms of aggressive periodontitis are still unknown, as well as the effect of periodontal therapy on these parameters. The aim of this prospective study was to evaluate clinical and immune responses of patients with AgP undergoing nonsurgical treatment. MATERIAL AND METHODS: Eighteen patients with GAgP, 10 with LAgP and 10 healthy participants were included in this study. AgP participants were submitted to scaling and root planing plus systemic antibiotics (amoxicillin and metronidazole). At baseline and 1-year follow-up were measured clinical parameters, such as probing depth [PD] and clinical attachment loss [CAL], and the levels of 10 immunological mediators (GM-CSF, M-CSF, MCP-1, ICAM-1, CXCL8, IL-1ß, TNF-α, IL-17, IL-4, and IL-10) in the gingival crevicular fluid (GCF) of selected sites [AgP forms: PD ≥ 6 mm or the deepest, bleeding on probing (BoP) and bone loss measured by periapical radiography; healthy individuals: PD ≤ 3 mm, no BoP, no bone loss] and serum. RESULTS: After periodontal treatment both forms of AgP presented a significant reduction of PD and CAL, an increase of GM-CSF, ICAM-1, MCP-1, TNF-α, IL-17, IL-4, and IL-10 in the GCF, as well as of GM-CSF and IL-4 in the serum, and a reduction in the serum concentration of IL-1ß. Serum levels of M-CSF, ICAM-1, and MCP-1 remained significantly below those found in healthy individuals in both forms of AgP even after therapy. An increase in the systemic or local levels of MCP-1, ICAM-1 and the anti-inflammatory profile (IL-4, IL-10) was correlated with an improvement in clinical parameters of LAgP patients. Also, a local reduction of IL-1ß levels in both forms of AgP was correlated with an increase in the clinical attachment gain. CONCLUSION: Nonsurgical periodontal therapy was successful in improving clinical parameters and modulating the immune response in both forms of AgP. However, this therapeutic approach does not seem to affect the deficient level of important serum mediators involved in mechanisms of cell transmigration.

Long-term outcomes from implants installed by using split-crest technique in posterior maxillae: 10 years of follow-up.

OBJECTIVE: The aim of the present 10-year retrospective study was to evaluate the success and survival rates of narrow diameter implants (NDIs) placed in combination with a split-crest technique. MATERIALS AND METHODS: Twenty-one healthy individuals who received prosthetic rehabilitation supported by narrow diameter implants (NDIs) installed in atrophic maxillary posterior areas immediately after split-crest procedure were included in the study. Six to eight weeks after implant placement, the prosthetic rehabilitations were delivered. Periapical radiographs were taken at the 6-month and 10-year time interval after implant loading to assess bone marginal level around the implants. In addition, survival and success indexes were also obtained at these time intervals. RESULTS: Forty NDIs were placed in 21 patients. At the end of the 10-year follow-up period, seven patients had dropped out, two implants were lost, and nine prostheses presented some type of deficiency (ceramic fracture or retaining screw fracture). At the 10-year time interval, the implant survival rate was 97% and the success rate was 95%. The marginal bone loss at the 6-month and 10-year time intervals was, respectively, 0.47 (SD 0.91) mm and 1.93 (SD 0.93) mm. CONCLUSION: Narrow diameter implants installed immediately after split-crest procedure may successfully support prosthetic rehabilitations after long-time intervals.

Anatomical evaluation of some morphological abnormalities related to periodontal diseases

The presence of some dental abnormalities as a predisposal factor to installation of localized periodontal alterations. The present study was to evaluate the frequency of development abnormalities present on a sample of molars that may predispose to occurrence and progression of periodontal disease. Two hundred and seventy seven molars (141 maxillary and 136 mandibular molars) were selected for this study. The evaluations were performed by two examiners together who was trained and calibrated for the study. All measurements were made by direct visualization with a magnifying glass. The following clinical parameters were measured: Enamel cervical projections; Root trunk: in the three different extensions (<3 mm, >3 mm and <6 mm, >6 mm); Enamel pearls: presence (1) or absence (0). The anatomic observations were made on four surfaces of the tooth: mesial, distal, vestibular and palatal/lingual. Descriptive statistics and percentage distribution were performed. A total of 130 molars showed at least some degree of enamel cervical projection and the most frequent score was the degree 1, according to Masters and Hoskins classification. Fifteen teeth presented enamel pearls and the root trunk was more evident on the group with variation from 3 to 6 mm of extension, observed in 64 teeth. It can be concluded that the presence of development abnormalities is a frequent finding in molars and it has to be taken into consideration during periodontal examination and therapy.

Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.

BACKGROUND AND OBJECTIVE: This study evaluated the effect of smoking on the gene expression of interleukin-1alpha, -1ra, -6, -8 and -10, tumor necrosis factor-alpha, matrix metalloproteinase (MMP)-2 and -8, receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin, in sites with periodontitis. MATERIAL AND METHODS: Gingival biopsies were divided into three groups: the healthy group (periodontally healthy subjects; n=10); the periodontitis group [subjects with severe chronic periodontitis who never smoked (probing depth>or=7 mm) (n=25)]; and the smoking group (subjects diagnosed with severe chronic periodontitis who smoked>or=1 pack per day for at least 10 years; n=25). Gene and protein expressions were analyzed by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. RESULTS: Data analysis demonstrated that, except for MMP-8 and osteoprotegerin, the levels of all factors were increased by inflammation (p<0.001). The levels of interleukin-1alpha, -1ra, -6 and -8, and RANKL, were higher in smokers with periodontitis compared with controls, whereas the levels of interleukin-10, MMP-8 and osteoprotegerin were lower (p<0.001). Smoking lowered the levels of interleukin-1alpha, -8, -10, tumor necrosis factor-alpha, MMP-8 and osteoprotegerin, and increased the levels of interleukin-6 and -1ra in sites with a comparable type of periodontitis (p<0.001). CONCLUSION: In conclusion, smoking modulates gene expression in the periodontium, and the influence of smoking on periodontal disease may involve effects of interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios.